Search Results - "Perdigoto AL"

Towards insulin independence in type 1 diabetes: Prospects for prevention and cure.

Authors: Sydney GI Perdigoto AL Herold KC

Source: PLoS medicine [PLoS Med] 2025 Nov 25; Vol. 22 (11), pp. e1004813. Date of Electronic Publication: 2025 Nov 25 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet ISSN: 1549-1676 (Electronic) Linking ISSN: 15491277 NLM ISO Abbreviation: PLoS Med Subsets: MEDLINE

Immune checkpoint inhibitor-induced diabetes can potentially be effectively treated with infliximab: a case report of two patients.

Authors: Savion Gaiger N Hurwitz ME Hafez N et al.

Source: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2025 Nov 07; Vol. 16, pp. 1697724. Date of Electronic Publication: 2025 Nov 07 (Print Publication: 2025).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE

TCR2HLA: Calibrated inference of HLA genotypes from TCR repertoires enables identification of immunologically relevant metaclonotypes.

Authors: Mayer-Blackwell, Koshlan Minervina, Anastasia Pogorelyy, Mikhail et al.

Source: PLoS Computational Biology. 1/16/2026, Vol. 22 Issue 1, p1-22. 22p.

Multigland dysfunction from immune-checkpoint inhibitors: a case of hypothyroidism, diabetes, and adrenal insufficiency.

Authors: Vengilote, Ranjini Onwudiwe, Oyiyechukwu Yousef, Alshaima et al.

Source: JCEM Case Reports. Mar2026, Vol. 4 Issue 3, p1-6. 6p.

Immune checkpoint inhibitor therapy and risk of type 1 diabetes mellitus in metastatic cancer patients.

Authors: Lin, Ming-Hsun Ye, Ren-Hua Jhou, Hong-Jie et al.

Source: Diabetology & Metabolic Syndrome. 10/3/2025, Vol. 17 Issue 1, p1-11. 11p.

Factors that increase class I MHC expression may contribute to the development of immune checkpoint inhibitor-induced diabetes.

Authors: Aizenbud L Savion Gaiger N Perdigoto AL et al.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Sep 10; Vol. 13 (9). Date of Electronic Publication: 2025 Sep 10.

Publication Type: Journal Article

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Autoimmune origin for immune checkpoint inhibitor-diabetes revealed by deep immune phenotyping of the pancreas.

Authors: Quandt Z Young A Barlow GL et al.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Aug 14; Vol. 13 (8). Date of Electronic Publication: 2025 Aug 14.

Publication Type: Journal Article; Case Reports

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

On feature selection to disentangle cell type and state transcriptional programs.

Authors: Wang, Jiayi Crowell, Helena L. Robinson, Mark D.

Source: BMC Genomics. 11/6/2025, Vol. 26 Issue 1, p1-9. 9p.

Immune Checkpoint Inhibitor-Induced Hypophysitis and Patterns of Loss of Pituitary Function.

Authors: Jessel S Weiss SA Austin M et al.

Source: Frontiers in oncology [Front Oncol] 2022 Mar 08; Vol. 12, pp. 836859. Date of Electronic Publication: 2022 Mar 08 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Alterations of circulating innate lymphoid cells in recent‐onset type 1 diabetes.

Authors: Roig, Ariadna Perna‐Barrull, David Aguilera, Eva et al.

Source: Clinical & Translational Immunology. Jun2026, Vol. 15 Issue 6, p1-18. 18p.

Impact of Hyperglycemia During Immune Checkpoint Inhibitor Treatment for Advanced Non--Small Cell Lung Cancer: A Retrospective, Single-Center Study.

Authors: Thurman, Allison L. Storey, Susan Reeves, David J.

Source: Journal of Hematology Oncology Pharmacy. Jun2026, Vol. 16 Issue 3, p96-107. 12p.

免疫检查点抑制剂相关糖尿病患者人类 白细胞抗原Ⅰ及Ⅱ类基因型分析.

Alternate Title: Analysis of human leukocyte antigen class Ⅰ and Ⅱ genotypes in immune checkpoint inhibitor-associated diabetes mellitus.

Authors: 付怡雯 赵立玲 管高鹏 et al.

Source: Chinese Journal of Diabetes Mellitus. May2026, Vol. 18 Issue 5, p433-439. 7p.

1 型糖尿病免疫治疗药物研究进展.

Alternate Title: Advances in immunotherapeutic drugs for type 1 diabetes.

Authors: 顾愹 杨涛 郭立新

Source: Chinese Journal of Diabetes Mellitus. May2026, Vol. 18 Issue 5, p484-490. 7p.

Establishment of reverse genetics systems for Colorado tick fever virus.

Authors: Minami, Shohei Nouda, Ryotaro Hirai, Katsuhisa et al.

Source: PLoS Pathogens. 2/14/2025, Vol. 21 Issue 2, p1-19. 19p.

NLRC5 p.Pro191Leu as a genetic susceptibility factor in anti-PIT-1 hypophysitis.

Authors: Urai S Bando H Yamamoto M et al.

Source: Journal of endocrinological investigation [J Endocrinol Invest] 2026 May 26. Date of Electronic Publication: 2026 May 26.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: Italy NLM ID: 7806594 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1720-8386 (Electronic) Linking ISSN: 03914097 NLM ISO Abbreviation: J Endocrinol Invest Subsets: MEDLINE

Challenges in subtyping disease entities of thyroid dysfunction following combined immune checkpoint inhibitor therapy: a case report.

Authors: Thomsen, Marco Juul Andersen, Stine Linding Torp, Nanna Maria Uldall et al.

Source: Thyroid Research. 7/15/2025, Vol. 18 Issue 1, p1-6. 6p.

Cardiovascular toxicities of immune therapies for cancer – a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio‐Oncology.

Authors: Tocchetti, Carlo Gabriele Farmakis, Dimitrios Koop, Yvonne et al.

Source: European Journal of Heart Failure. Oct2024, Vol. 26 Issue 10, p2055-2076. 22p.

Coxsackie B Virus-Induced Autoimmunity in Type 1 Diabetes Mellitus: Mechanisms and Emerging Prevention Strategies.

Alternate Title: المناعة الذاتية المحفزة بفيروس كوكسساكي B في داء السكري من النوع الأول: الآليات واستراتيجيات الوقاية الناشئة.

Authors: Enitan, Seyi Samson Akele, Richard Yomi Osakue, Osareniro Eguagie et al.

Source: Jordan Medical Journal. Mar2026, Vol. 60 Issue 2, p194-228. 35p.

Acquired Hemophilia A After Neoadjuvant Immunotherapy for Renal Cell Carcinoma.

Authors: SUN, GRACE ETESHOLA, ELIAS O. U. HADFIELD, MATTHEW J. et al.

Source: Rhode Island Medical Journal. Feb2026, Vol. 109 Issue 2, p14-18. 5p.

Insulin resistance and cancer: molecular links and clinical perspectives.

Authors: Caturano A Erul E Nilo R et al.

Source: Molecular and cellular biochemistry [Mol Cell Biochem] 2025 Jul; Vol. 480 (7), pp. 3995-4014. Date of Electronic Publication: 2025 Mar 15.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Country of Publication: Netherlands NLM ID: 0364456 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-4919 (Electronic) Linking ISSN: 03008177 NLM ISO Abbreviation: Mol Cell Biochem Subsets: MEDLINE